Literature DB >> 24331295

Assessment of the dietary intake of total flavan-3-ols, monomeric flavan-3-ols, proanthocyanidins and theaflavins in the European Union.

Anna Vogiatzoglou1, Angela A Mulligan2, Robert N Luben2, Marleen A H Lentjes2, Christian Heiss3, Malte Kelm3, Marc W Merx3, Jeremy P E Spencer1, Hagen Schroeter4, Gunter G C Kuhnle1.   

Abstract

Dietary interventions with flavan-3-ols have shown beneficial effects on vascular function. The translation of these findings into the context of the health of the general public requires detailed information on habitual dietary intake. However, only limited data are currently available for European populations. Therefore, in the present study, we assessed the habitual intake of flavan-3-ol monomers, proanthocyanidins (PA) and theaflavins in the European Union (EU) and determined their main food sources using the EFSA (European Food Safety Authority) Comprehensive European Food Consumption Database. Data for adults aged 18-64 years were available from fourteen European countries, and intake was determined using the FLAVIOLA Flavanol Food Composition Database, developed for the present study and based on the latest US Department of Agriculture and Phenol-Explorer databases. The mean habitual intake of flavan-3-ol monomers, theaflavins and PA ranged from 181 mg/d (Czech Republic) to 793 mg/d (Ireland). The highest intakes of flavan-3-ol monomers and theaflavins were observed in Ireland (191/505 mg/d) and the lowest intakes in Spain (24/9 mg/d). In contrast, the daily intake of PA was highest in Spain (175 mg/d) and lowest in The Netherlands (96 mg/d). Main sources were tea (62%), pome fruits (11%), berries (3%) and cocoa products (3%). Tea was the major single contributor to monomer intake (75%), followed by pome fruits (6%). Pome fruits were also the main source of PA (28%). The present study provides important data on the population-based intake of flavanols in the EU and demonstrates that dietary intake amounts for flavan-3-ol monomers, PA and theaflavins vary significantly across European countries. The average habitual intake of flavan-3-ols is considerably below the amounts used in most dietary intervention studies.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24331295     DOI: 10.1017/S0007114513003930

Source DB:  PubMed          Journal:  Br J Nutr        ISSN: 0007-1145            Impact factor:   3.718


  32 in total

1.  Acute effects of cocoa flavanols on visual working memory: maintenance and updating.

Authors:  Ahmet Altınok; Aytaç Karabay; Elkan G Akyürek
Journal:  Eur J Nutr       Date:  2022-01-15       Impact factor: 5.614

2.  Assessing Variability in Vascular Response to Cocoa With Personal Devices: A Series of Double-Blind Randomized Crossover n-of-1 Trials.

Authors:  Mariam Bapir; Paola Campagnolo; Ana Rodriguez-Mateos; Simon S Skene; Christian Heiss
Journal:  Front Nutr       Date:  2022-06-13

3.  Dietary intake of (poly)phenols in children and adults: cross-sectional analysis of UK National Diet and Nutrition Survey Rolling Programme (2008-2014).

Authors:  Nida Ziauddeen; Alice Rosi; Daniele Del Rio; Birdem Amoutzopoulos; Sonja Nicholson; Polly Page; Francesca Scazzina; Furio Brighenti; Sumantra Ray; Pedro Mena
Journal:  Eur J Nutr       Date:  2018-11-17       Impact factor: 5.614

4.  Estimated dietary intakes and sources of flavanols in the German population (German National Nutrition Survey II).

Authors:  Anna Vogiatzoglou; Thorsten Heuer; Angela A Mulligan; Marleen A H Lentjes; Robert N Luben; Gunter G C Kuhnle
Journal:  Eur J Nutr       Date:  2013-08-06       Impact factor: 5.614

5.  Effects of Cocoa-Derived Polyphenols on Cognitive Function in Humans. Systematic Review and Analysis of Methodological Aspects.

Authors:  Paloma K Barrera-Reyes; Josué Cortés-Fernández de Lara; Melissa González-Soto; M Elizabeth Tejero
Journal:  Plant Foods Hum Nutr       Date:  2020-03       Impact factor: 3.921

6.  Effect of cocoa flavanol supplementation for the prevention of cardiovascular disease events: the COcoa Supplement and Multivitamin Outcomes Study (COSMOS) randomized clinical trial.

Authors:  Howard D Sesso; JoAnn E Manson; Aaron K Aragaki; Pamela M Rist; Lisa G Johnson; Georgina Friedenberg; Trisha Copeland; Allison Clar; Samia Mora; M Vinayaga Moorthy; Ara Sarkissian; William R Carrick; Garnet L Anderson
Journal:  Am J Clin Nutr       Date:  2022-06-07       Impact factor: 8.472

7.  Cocoa flavanol consumption improves cognitive function, blood pressure control, and metabolic profile in elderly subjects: the Cocoa, Cognition, and Aging (CoCoA) Study--a randomized controlled trial.

Authors:  Daniela Mastroiacovo; Catherine Kwik-Uribe; Davide Grassi; Stefano Necozione; Angelo Raffaele; Luana Pistacchio; Roberta Righetti; Raffaella Bocale; Maria Carmela Lechiara; Carmine Marini; Claudio Ferri; Giovambattista Desideri
Journal:  Am J Clin Nutr       Date:  2014-12-17       Impact factor: 7.045

8.  Flavonoid intake in European adults (18 to 64 years).

Authors:  Anna Vogiatzoglou; Angela A Mulligan; Marleen A H Lentjes; Robert N Luben; Jeremy P E Spencer; Hagen Schroeter; Kay-Tee Khaw; Gunter G C Kuhnle
Journal:  PLoS One       Date:  2015-05-26       Impact factor: 3.240

9.  A Single Oral Administration of Theaflavins Increases Energy Expenditure and the Expression of Metabolic Genes.

Authors:  Naoto Kudo; Yasunori Arai; Yoshitomo Suhara; Takeshi Ishii; Tsutomu Nakayama; Naomi Osakabe
Journal:  PLoS One       Date:  2015-09-16       Impact factor: 3.240

10.  Polyphenolic Compounds of Crataegus Berry, Leaf, and Flower Extracts Affect Viability and Invasive Potential of Human Glioblastoma Cells.

Authors:  Natalia Żurek; Olena Karatsai; Maria Jolanta Rędowicz; Ireneusz Tomasz Kapusta
Journal:  Molecules       Date:  2021-05-01       Impact factor: 4.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.